Sabby Management’s ReShape Lifesciences Inc. Common Stock RSLS Stock Holding History

Sabby Management’s Portfolio RSLS Stock Details RSLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-732,648	Closed	-$187K	–	149
2018 Q4	$187K	Buy	732,648 +729,350	+22,115%	+$1.72M	0.04%	71
2018 Q3	$20K	Buy	3,298 +1,616	+96%	+$139K	﹤0.01%	118
2018 Q2	$542K	Buy	+1,682	New	+$1.44M	0.08%	81

Sabby Management's RSLS Position: Q1 2019 in Review

Sabby Management sold out of ReShape Lifesciences Inc. Common Stock (RSLS) in Q1 2019, closing a stake of 732,648 shares — an estimated $187K sold.

Sabby Management first reported a position in RSLS in Q2 2018 and held it in 3 quarters. The position peaked at $542K in Q2 2018. 0 funds tracked by Wall St. Rank hold RSLS as of Q1 2019.

Sabby Management reported no remaining ReShape Lifesciences Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
Sabby Management sold 732,648 ReShape Lifesciences Inc. Common Stock shares in Q1 2019, an estimated $187K.
Sabby Management first reported a position in ReShape Lifesciences Inc. Common Stock in Q2 2018 and held it in 3 quarters.
Sabby Management's ReShape Lifesciences Inc. Common Stock position peaked at $542K in Q2 2018.
0 funds tracked by Wall St. Rank held ReShape Lifesciences Inc. Common Stock as of Q1 2019.

Based on Sabby Management's 13F filing for Q1 2019, filed 15 May 2019.